CSPC PHARMACEUT.GR. ADR4 (CVGU) — Working Capital to Net Assets Ratio
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Working Capital to Net Assets ratio of 34.9% as of December 2025. Working capital of €12.07 Billion (current assets of €22.25 Billion minus current liabilities of €10.18 Billion) is measured against net assets of €34.55 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of CSPC PHARMACEUT.GR. ADR4 to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CSPC PHARMACEUT.GR. ADR4 Working Capital to Net Assets (2021–2025)
This chart shows how CSPC PHARMACEUT.GR. ADR4's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 34.9%, reflecting working capital of €12.07 Billion against net assets of €34.55 Billion EUR. For the complete balance sheet picture, see CSPC PHARMACEUT.GR. ADR4 balance sheet assets.
Annual Working Capital to Net Assets for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are CSPC PHARMACEUT.GR. ADR4's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 34.9% | €12.07 Billion | €34.55 Billion | €22.25 Billion | €10.18 Billion | ▼ -1.2 pp |
| 2024 | 36.2% | €12.25 Billion | €33.87 Billion | €21.89 Billion | €9.63 Billion | ▼ -11.1 pp |
| 2023 | 47.3% | €16.56 Billion | €35.02 Billion | €26.74 Billion | €10.18 Billion | ▼ -0.1 pp |
| 2022 | 47.4% | €15.00 Billion | €31.64 Billion | €23.96 Billion | €8.96 Billion | ▼ -1.5 pp |
| 2021 | 48.9% | €13.11 Billion | €26.83 Billion | €20.34 Billion | €7.23 Billion | — |